Plasmid DNA of high quality purified by activated charcoal

Journal of Bioscience and Bioengineering

Volumn 110, Issue 5, 2010, Pages 608-613

  Kim, Jae Young ^a   Cho, Chunghee ^b   Cho, Byung Nam ^a  

^a The Catholic University of Korea   (South Korea)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Activated charcoal; Plasmid DNA; Purity; Safety

Indexed keywords

ACTIVATED CHARCOAL; DNA VACCINE; DOSE-DEPENDENT; HIGH PURITY; HIGH QUALITY; NUCLEOTIDE FRAGMENT; PLASMID DNA; PURITY; SAFETY; STUDY AND APPLICATIONS;

GENE THERAPY; GENETIC ENGINEERING; MICROBIOLOGY; NUCLEOTIDES; PURIFICATION; VACCINES;

DNA;

ACTIVATED CARBON; PLASMID DNA; RIBONUCLEASE;

ANIMAL EXPERIMENT; ARTICLE; DNA EXTRACTION; DNA PURIFICATION; ELECTROPHORESIS; ENZYME MECHANISM; ESCHERICHIA COLI; LYSIS; NONHUMAN;

BIOTECHNOLOGY; CHARCOAL; DNA, RECOMBINANT; ESCHERICHIA COLI; GENE THERAPY; HUMANS; HYDROGEN-ION CONCENTRATION; PLASMIDS; RIBONUCLEASES; TRANSFORMATION, GENETIC; VACCINES, DNA;

EID: 77957318541     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2010.06.008     Document Type: Article

References (34)

1. Sambrook J., Russell D.W. Preparation of plasmid DNA by alkaline lysis with SDS, Molecular cloning 2001, 1.31-1.41. Cold Spring Harbor Laboratory Press.
2. Ahn J.M., Jung H.K., Cho J.H., Choi D., Mayo K.E., Cho B.N. Changes in the reproductive functions of mice due to injection of a plasmid expressing an inhibin -subunit into muscle: a transient transgenic model. Mol. Cells 2004, 18:79-86.
3. Kim M.N., Park M.N., Jung H.K., Cho C., Mayo K.E., Cho B.N. Changes in the reproductive function and developmental phenotypes in mice following intramuscular injection of an activin betaA-expressing plasmid. Reprod. Biol. Endocrinol. 2008, 6:63-73.
4. Friedmann T. The road toward human gene therapy-a 25-year perspective. Ann. Med. 1997, 29:575-577.
5. Liljeqvist S., Stahl S. Production of recombinant subunit vaccines: protein immunogenes, live delivery systems and nucleic acid vaccines. J. Biotechnol. 1999, 73:1-33.
6. 3 fermentation scale for an influenza pandermic. Biotechnol. Prog. 2005, 21:1577-1592.
7. Soda Y., Tani K., Bai Y., Saiki M., Chen M., Izawa K., Kobayashi S., Takahashi S., Uchimaru K., Kuwabara T., Warashina M., Tanabe T., Miyoshi H., Sugita K., Nakazawa S., Tojo A., Taira K., Asano S. A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 2004, 104:356-363.
8. Cho Y.H., Park H., Cho E.S., Kim W.J., Kang B.S., Park B.Y., Kim Y.J., Lee Y.I., Chang S.I., Park K. A novel way of therapeutic angiogenesis using an adeno-associated virus-mediated angiogenin gene transfer. Exp. Mol. Med. 2007, 39:412-418.
9. Bonini C., Bondanza A., Perna S.K., Kaneko S., Traversari C., Ciceri F., Bordignon C. The suicide gene therapy challenge: How to improve a successful gene therapy approach. Mol. Ther. 2007, 15:1248-1252.
10. Koh K., Lee K., Ahn J.H., Kim S. Human cytomegalovirus infection downregulates the expression of glial fibrillary acidic protein in human glioblastoma U373MG cells: Identification of viral genes and protein domains involved. J. Gen. Virol. 2009, 90:954-962.
11. Griesenbach U., Alton E., U.K. Cystic fibrosis gene therapy consortium gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy. Adv. Drug. Deliv. Rev. 2009, 61:128-139.
12. Sebestyén M.G., Hegge J.O., Noble M.A., Lewis D.L., Herweijer H., Wolff J.A. Progress toward a non-viral gene therapy protocol for the treatment of anemia. Hum. Gene Ther. 2007, 18:269-285.
13. Raper J., Portela M.P., Redpath M., Tomlinson S., Lugli E., Green H. Natural immunity to human African trypanosomiasis: trypanosome lytic factors and the blood incubation infectivity test. Trans. R. Soc. Trop. Med. Hyg. 2002, Suppl 1:145-150.
14. Check E. Gene therapy: A tragic setback. Nature 2002, 420:116-118.
15. Cai Y., Rodriguez S., Hebel H. DNA vaccine manufacture: scale and quality. Expert Rev. Vaccine 2009, 8:1277-1291.
16. Birnboim H.C., Doly J. A rapid alkaline extraction procedure for screening recombinant DNA. Nucleic Acids Res. 1979, 7:1513-1523.
17. Meacle F.J., Lander R., Shamlou P.A., Titchener-Hooker N.J. Impact of engineering flow conditions on plasmid DNA yield and purity in chemical cell lysis operations. Biotechnol. Bioeng. 2004, 87:293-302.
18. Prazers D.M.F., Ferreira G.N.M., Monteiro G.A., Cooney C.L., Cabral J.M. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: Problems and bottlenecks. Trends Biotechnol. 1999, 17:169-174.
19. Paril A., Horner D., Ganja R., Jungbauer A. Adsorption of plasmid DNA on microparticulate charged surface. J. Biotechnol. 2009, 141:47-57.
20. Tarmann C., Jungbauer A. Adsorption of plasmid DNA on anion exchange chromatography media. J. Sep. Sci. 2008, 31:2605-2618.
21. Guerrero-German P., Prazeres D.M.F., Guzman R., Montesinos-Cisneros R.M., Tejeda-Mansir A. Purification of plasmid DNA using tangential flow filtration and tandem anion-exchange membrane chromatography. Bioprocess. Biosyst. Eng. 2008, 32:615-623.
22. Schleef M., Schmidt T. Animal-free production of ccc-supercoiled plasmids for research and clinical applications. J. Gene Med. 2004, 6:S45-S53.
23. Voss C., Lindau D., Flaschel E. Production of recombinant RNase Ba and its application in downstream processing of plasmid DNA for pharmaceutical use. Biotechnol. Prog. 2006, 22:737-744.
24. Do N., Adams R.P. A simple technique for removing the plant polysaccharide contaminants from DNA. Biotechniques 1991, 10:162-166.
25. Norberg J. Association of protein-DNA recognition complexes: electrostatic and nonelectrostatic effects. Arch. Biochem. Biophys. 2003, 410:48-68.
26. Misra V.K., Hecht J.L., Sharp K.A., Friedman R.A., Honiq B. Salt effects on protein-DNA interactions the lambda cl repressor and EcoRI endonuclease. J. Mol. Biol. 1994, 238:264-280.
27. Alvarez B., Guijarro J.A. Recovery of Flavobacterium psychrophilum viable cells using a charcoal-based solid medium. Lett. Appl. Microbiol. 2007, 44:569-572.
28. Coelho C., Oliveira A.S., Pereira M.F.R., Nunes O.C. The influence of activated carbon surface properties on the adsorption of the herbicide molinate and the bio-regeneration of the adsorbent. J. Hazad. Mater. 2006, 138:343-349.
29. Eyer F., Jung N., Neuberger H., Witte A., Poethko P., Henke T., Zilker T. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats. Basic Clin. Pharmacol. Toxicol. 2007, 102:337-346.
30. 2 Fluoroalkanes upon selected preconcentration adsorbents:I. Carbon molecular sieves and activated charcoals. J. Chromatogr. A 2006, 1133:49-57.
31. Hammer D., Keller C., McLaughlin M.J., Hamon R.E. Fixation of metals in soil constituents and potential remobilization by hyperaccumulating and non-hyeraccumulating plants: Results from an isotopic dilution study. Environ. Pollut. 2006, 143:407-415.
32. Wang S.Y., Tsai M.H., Lo S.F., Tsai M.J. Effects of manufacturing conditions on the adsorption capacity of heavy metal ions by Makino bamboo charcoal. Bioresour. Technol. 2008, 16:1-7.
33. Itoh M., Carninci P., Nagaoka S., Okazaki Y., Muramatsu M., Hayashizaki Y. Simple and rapid preparation of plasmid template by a filtration method using microtiter filter plates. Nucleic Acids Res. 1997, 25:1315-1316.
34. Urthaler J., Buchinger W., Necina R. Improved downstream process for the production of plasmid DNA for gene therapy. Acta Biochim. Pol. 2005, 52:703-711.